Shares of Cable and wire maker KEI Industries Ltd. fell as much as 8% on Thursday, October 16, in response to the September quarter results, which were reported after market hours on Wednesday. KEI ...

Treasury Secretary Scott Bessent said the United States plans to set price floors across sectors such as rare earths, suggesting a significant escalation in the administration’s market interventions ...

An executive branch focus on PFAS with the greatest potential to harm, nationwide testing standards, clarity over whether existing federal rules preempt state regulations, and new federal ...

Tvardi Therapeutics recently announced preliminary results from its Phase 2 REVERT trial in idiopathic pulmonary fibrosis, revealing that TTI-101 did not show a significant difference in efficacy ...

One item to point out is that Tvardi Therapeutics (NASDAQ:TVRD) brought its pipeline forth to public trading because of a merger it enacted with Cara Therapeutics and thus was able to list on the ...

NEW YORK, Oct 13 (Reuters) - JPMorgan Chase (JPM.N), opens new tab announced plans on Monday to hire bankers and invest up to $10 billion in U.S. companies critical to national security and economic ...

Foxconn has pledged to invest Rs 15,000 crore in Tamil Nadu, creating 14,000 skilled jobs, according to the state’s industries minister. He called it Tamil Nadu’s biggest-ever engineering job boost.

JPMorgan Chase & Co. vowed to funnel $1.5 trillion into industries that bolster US economic security and resiliency over the next 10 years — an initiative that will invest billions of dollars in ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Tvardi Therapeutics shares were 30% lower, at $7.19, in premarket trading after the company said its phase 2 study for TTI-101 didn't meet its goals. TTI-101 is a small molecule therapy targeting ...